Mary E Lebsack
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
- Co-authors
- Janice L. Lookabaugh (1 shared paper)G. Campion (1 shared paper)Gary V. Gordon (1 shared paper)Joan M Korth-Bradley (1 shared paper)Abbe Sue Rubin (1 shared paper)Roberta K Hanna (1 shared paper)Donna K. Simcoe (1 shared paper)Allen J. Sedman (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Oncology (2 papers)Annals of Pharmacotherapy (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Mary E Lebsack
11 papers receiving 449 citations
Peers
Comparison fields: 5 of 58
- Rheumatology 211
- Pharmacology 79
- Pharmaceutical Science 42
- Pharmacology 71
- Hematology 44
Countries citing papers authored by Mary E Lebsack
This map shows the geographic impact of Mary E Lebsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E Lebsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E Lebsack more than expected).
Fields of papers citing papers by Mary E Lebsack
This network shows the impact of papers produced by Mary E Lebsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E Lebsack. The network helps show where Mary E Lebsack may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary E Lebsack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 213 | |
| 2 | 2000 | 128 | |
| 3 | 1989 | 92 | |
| 4 | 1992 | 32 | |
| 5 | Safety of FLT3 ligand in healthy volunteers | 1997 | 15 |
| 6 | 1997 | 15 | |
| 7 | 1996 | 10 | |
| 8 | 1993 | 7 | |
| 9 | 1988 | 6 | |
| 10 | 1991 | 2 | |
| 11 | 1992 | 2 |
About Mary E Lebsack
Mary E Lebsack is a scholar working on Pharmacology, Hematology, Pharmaceutical Science, Rheumatology and Pharmacology, having authored 11 papers that have together received 522 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Solubulity and Delivery Systems (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Atrial Fibrillation Management and Outcomes (1 paper), Acute Myeloid Leukemia Research (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Rheumatology (211 citations), Pharmacology (79 citations), Pharmaceutical Science (42 citations), Pharmacology (71 citations) and Hematology (44 citations). Mary E Lebsack has collaborated with scholars based in United States. Frequent co-authors include Janice L. Lookabaugh, G. Campion, Gary V. Gordon, Joan M Korth-Bradley, Abbe Sue Rubin, Roberta K Hanna, Donna K. Simcoe, Allen J. Sedman, Jerome J. Schentag and John H. Wilton. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Annals of Pharmacotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.